Search research articles
Contact Us
Filters
Showing results (51-60 of 103) with videos related to
Page
of 11
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 2, 2020
Predictors of prostate-specific antigen testing in men aged ≥55 years: A cross-sectional study based on patient-reported outcomes
Joon Yau Leong, Thenappan Chandrasekar, Alejandro Berlin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 17, 2024
The use of focal therapy for the treatment of prostate cancer in Canada Where are we, how did we get here, and where are we going?
Ravi Kumar, Sangeet Ghai, Antonio Finelli, et al.
The Journal of Urology
|
July 27, 2016
Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance
Nathan Perlis, Rashid Sayyid, Andrew Evans, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 13, 2021
Detection of clinically significant prostate cancer with <sup>18</sup>F-DCFPyL PET/multiparametric MR
Ur Metser, Claudia Ortega, Nathan Perlis, et al.
European Urology Oncology
|
June 1, 2024
Prostate Magnetic Resonance Imaging Using the Prostate Imaging for Recurrence Reporting (PI-RR) Scoring System to Detect Recurrent Prostate Cancer: A Systematic Review and Meta-analysis
Felipe A Mourato, Luiza G Schmitt, Miriana Mariussi, et al.
Radiology
|
March 5, 2024
MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial
Sangeet Ghai, Antonio Finelli, Kateri Corr, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 22, 2023
The role of [<sup>18</sup>F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer
Adriano Basso Dias, Seyed Ali Mirshahvalad, Claudia Ortega, et al.
Urologic Oncology
|
January 13, 2023
Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillance
Guan Hee Tan, Dominik Deniffel, Antonio Finelli, et al.
European Radiology
|
May 4, 2022
Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy
Dominik Deniffel, Nathan Perlis, Sangeet Ghai, et al.
Urologic Oncology
|
February 17, 2019
Population-based outcomes of men with a single negative prostate biopsy: Importance of continued follow-up among older patients
Rashid K Sayyid, Shabbir M H Alibhai, Rinku Sutradhar, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 103) with videos related to
Sort By:
Page
of 11
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 2, 2020
Predictors of prostate-specific antigen testing in men aged ≥55 years: A cross-sectional study based on patient-reported outcomes
Joon Yau Leong, Thenappan Chandrasekar, Alejandro Berlin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 17, 2024
The use of focal therapy for the treatment of prostate cancer in Canada Where are we, how did we get here, and where are we going?
Ravi Kumar, Sangeet Ghai, Antonio Finelli, et al.
The Journal of Urology
|
July 27, 2016
Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance
Nathan Perlis, Rashid Sayyid, Andrew Evans, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 13, 2021
Detection of clinically significant prostate cancer with <sup>18</sup>F-DCFPyL PET/multiparametric MR
Ur Metser, Claudia Ortega, Nathan Perlis, et al.
European Urology Oncology
|
June 1, 2024
Prostate Magnetic Resonance Imaging Using the Prostate Imaging for Recurrence Reporting (PI-RR) Scoring System to Detect Recurrent Prostate Cancer: A Systematic Review and Meta-analysis
Felipe A Mourato, Luiza G Schmitt, Miriana Mariussi, et al.
Radiology
|
March 5, 2024
MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial
Sangeet Ghai, Antonio Finelli, Kateri Corr, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 22, 2023
The role of [<sup>18</sup>F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer
Adriano Basso Dias, Seyed Ali Mirshahvalad, Claudia Ortega, et al.
Urologic Oncology
|
January 13, 2023
Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillance
Guan Hee Tan, Dominik Deniffel, Antonio Finelli, et al.
European Radiology
|
May 4, 2022
Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy
Dominik Deniffel, Nathan Perlis, Sangeet Ghai, et al.
Urologic Oncology
|
February 17, 2019
Population-based outcomes of men with a single negative prostate biopsy: Importance of continued follow-up among older patients
Rashid K Sayyid, Shabbir M H Alibhai, Rinku Sutradhar, et al.
Page
of 11